Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-03-22

Clinical Trial Update: Local Phase 4 Pan-European SMART Study [Phase 4]

View source ↗

Summary

A Phase 4 local Pan-European asthma trial (SMART study) sponsored by AstraZeneca has completed and posted results in March 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Symbicort (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2010-03-22